Department of Health and Human…

                                     Department of Health and Human Services · Centers for Disease Control and Prevention

Recommended Immunization Schedulefor Ages 0­6 Years UNITED STATES · 2007
                            Age   Birth          1            2      4      6      12     15     18   19­23                                                    2­3           4­6
 Vaccine                                       month        months months months months months months months                                                  years         years
                   1
                                                                            see
 Hepatitis B                      HepB                HepB                footnote                          HepB                                       HepB Series                                 Range of
                                                                             1                                                                                                                     recommended
                                                                                                                                                                                                   ages
               2
 Rotavirus                                                    Rota          Rota          Rota
                                                                                                                                                                                                   Catch-up
 Diphtheria,                                                                                                                                                                                       immunization
 Tetanus, Pertussis
                   3                                          DTaP         DTaP          DTaP                             DTaP                                             DTaP
                                                                                                                                                                                                   Certain
 Haemophilus                                                                                                                                                                                       high-risk groups
 influenzae type b
                   4                                           Hib           Hib          Hib4                Hib                                   Hib

                       5                                                                                                                                          PCV
 Pneumococcal                                                 PCV           PCV           PCV                PCV
                                                                                                                                                                   PPV

 Inactivated Poliovirus                                        IPV           IPV                              IPV                                                            IPV

 Influenza6                                                                                                         Influenza (Yearly)

 Measles,Mumps,
 Rubella
         7                                                                                                  MMR                                                            MMR

           8
 Varicella                                                                                                 Varicella                                                     Varicella

                   9
 Hepatitis A                                                                                                       HepA (2 doses)                             HepA Series

                       10
 Meningococcal                                                                                                                                                    MPSV4

This schedule indicates the recommended ages for routine administration of currently licensed childhood     of the combination are indicated and other components of the vaccine are not contraindicated and if
vaccines, as of December 1, 2006, for children through age 6 years. For additional information see          approved by the Food and Drug Administration for that dose of the series. Providers should consult the
www.cdc.gov/nip/recs/child-schedule.htm. Any dose not administered at the recommended age should            respective ACIP statement for detailed recommendations. Clinically significant adverse events that follow
be administered at any subsequent visit when indicated and feasible. Additional vaccines may be licensed    immunization should be reported to the Vaccine Adverse Event Reporting System (VAERS). Guidance about
and recommended during the year. Licensed combination vaccines may be used whenever any components          how to obtain and complete a VAERS form is available at www.vaers.hhs.gov or by telephone, 800-822-7967.

1. Hepatitis B vaccine (HepB). (Minimum age: birth)                                                         5. Pneumococcal vaccine. (Minimum age: 6 weeks for Pneumococcal Conjugate
   At birth:                                                                                                   Vaccine (PCV); 2 years for Pneumococcal Polysaccharide Vaccine (PPV))
   · Administer monovalent HepB to all newborns prior to hospital discharge.                                   · Administer PCV at ages 24-59 months in certain high-risk groups. Administer
   · If mother is HBsAg-positive, administer HepB and 0.5 mL of hepatitis B immune                               PPV to certain high-risk groups aged 2 years. See MMWR 2000; 49(RR-9):1-35.
     globulin (HBIG) within 12 hours of birth.                                                              6. Influenza vaccine. (Minimum age: 6 months for trivalent inactivated influenza
   · If mother's HBsAg status is unknown, administer HepB within 12 hours of birth.                            vaccine (TIV); 5 years for live, attenuated influenza vaccine (LAIV)
     Determine the HBsAg status as soon as possible and if HBsAg-positive, adminis-                            · All children aged 6­59 months and close contacts of all children aged 0­59
     ter HBIG (no later than age 1 week).                                                                        months are recommended to receive influenza vaccine.
   · If mother is HBsAg-negative, the birth dose can only be delayed with physician's                          · Influenza vaccine is recommended annually for children aged 59 months with
     order and mothers' negative HBsAg laboratory report documented in the infant's                              certain risk factors, healthcare workers, and other persons (including household
     medical record.                                                                                             members) in close contact with persons in groups at high risk. See MMWR
   Following the birth dose:                                                                                     2006; 55(RR-10);1-41.
   · The HepB series should be completed with either monovalent HepB or a combination                          · For healthy persons aged 5­49 years, LAIV may be used as an alternative to TIV.
     vaccine containing HepB. The second dose should be administered at age 1­2                                · Children receiving TIV should receive 0.25 mL if aged 6­35 months or 0.5 mL if
     months. The final dose should be administered at age 24 weeks. Infants born                                 aged 3 years.
     to HBsAg-positive mothers should be tested for HBsAg and antibody to HBsAg                                · Children aged